Displaying items by tag: department of pathology

The O’Neal Invests program funds UAB investigators starting new cancer-related projects to initiate key, preliminary work needed to enable competitive R01 applications from the NIH.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under

Yabing Chen, Ph.D., is the first researcher at the Birmingham VA to receive this highest honor for a non-physician scientist.

In this arteriolar niche, breast cancer stem cells and arteriolar endothelial cells cross-talk using a well-known signaling pathway. Targeting this pathway may offer therapeutic potential.

Sixto Leal, M.D., Ph.D., was featured in the “Front(line) and Center” category in the Pathologist's 2021 Power List recognizing some of the most inspirational pathologists and laboratory medicine professionals in the U.S. in 2021.

UAB students in the Honors College are equipping the next generation of scientists with cancer biology knowledge through hands-on experiments and interactive projects, helping to spread cancer awareness in Birmingham and surrounding communities.
Elizabeth Brown, Ph.D., has received a $3.1 million grant from the National Cancer Institute to study epigenetic contribution to the excess risk of a precursor of multiple myeloma in African Americans.
Blood shortages are common in the summer months, and COVID-19 has played havoc with usual donation patterns.
The lab’s clinical expertise combined with the powerful diagnostic capability of its instruments will allow UAB to offer patients increasingly targeted, personalized treatment.
Using spatial transcriptomics, UAB researchers set out to understand the differences and similarities between two viral infections causing acute lung injury, as it could improve patient care, as well as identify novel therapeutic targets.
Page 1 of 8